Stopping GLP-1 drugs can quickly erase cardiovascular benefits
Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, approximately one in eight U.S. adults now take these medications, which also provide cardiovascular benefits. However, when patients stop taking these drugs, they not only regain weight, but, according to a new study, they also incur increased risk of heart attack, stroke, and death compared to staying on the medication.
Type 2 Diabetes Risk Varies Widely in Young Adults. How GLP-1s Can Help
New research highlights a need for earlier, more tailored interventions to prevent type 2 diabetes in young adults with prediabetes. Klaus Vedfelt/Getty Images
Researchers found that type 2 diabetes risk varies among adults ages 18 to 40.
Those with high fasting glucose, especially if they qualified for GLP-1 treatment, had higher risk.
GLP-1 drugs and 8 healthy lifestyle habits may lower cardiovascular risk
How do GLP-1s affect bone health? New studies investigate
Could GLP-1 drugs cut the risk of complications after a heart attack?
Wegovy users may have 5 times risk of vision loss than those on Ozempic
Despite Side Effects, People Continue Taking Ozempic for Weight Loss
People who lose weight with GLP-1 drugs are likely to continue using the medication despite the side effects. Image Credit: geckophotos/Getty Images
A recent study found that many people using GLP-1 drugs for weight loss choose to continue the medication despite unpleasant side effects.
Mounjaro, Zepbound May Lower Risk of Eye Disease in People With Diabetes
Tirzepatide may help lower the risk of diabetic retinopathy, a diabetes complication that can lead to vision loss. Douglas Sacha/Getty Images
Weight loss medications Mounjaro and Zepbound, which contain the active ingredient tirzepatide, may lower the risk of diabetic retinopathy.
Why Some GLP-1 Users Say They’re Developing Scurvy
Reports of people developing scurvy while taking GLP-1 medications are on the rise. Milles Team/Shutterstock
Reports of GLP-1 users developing scurvy have increased in recent months.
GLP-1 drugs can lead to malnutrition since they reduce appetite and food consumption.
GLP-1s Combined With Healthy Habits May Improve Heart Health in Diabetes
Combining GLP-1 drugs with a healthy lifestyle may reduce cardiovascular risks in people with diabetes. Image Credit: Witthaya Prasongsin/Getty Images
A recent study found that people with type 2 diabetes who used GLP-1 receptor agonists (GLP-1 RAs) in combination with healthy lifestyle habits had a reduced risk of major adverse cardiovascular events.